Suppr超能文献

采用国际糖尿病联盟、美国国家胆固醇教育计划成人治疗专家组第三次报告及伊朗标准对代谢综合征患病率的评估:塔巴里队列研究结果

Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel- Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study.

作者信息

Bahar Adeleh, Kashi Zahra, Kheradmand Motahareh, Hedayatizadeh-Omran Akbar, Moradinazar Mahdi, Ramezani Fatemeh, Afshari Mahdi, Moosazadeh Mahmood

机构信息

Diabetes research center, Mazandaran University of medical sciences, Sari, Iran.

Health Sciences Research center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

J Diabetes Metab Disord. 2020 Jan 17;19(1):205-211. doi: 10.1007/s40200-020-00492-6. eCollection 2020 Jun.

Abstract

BACKGROUND

Metabolic syndrome is defined by co-incidence of multiple metabolic disorders such as central obesity, high triglycerides, low HDL, hyperglycemia and high blood pressure, which increases the risk of cardiovascular disease and diabetes. The aim of this study was to estimate the prevalence of metabolic syndrome using Adult Treatment Panel III (ATP-III), International Diabetes Federation (IDF) and Iranian criteria in large-scaled population based cohort study and to determine the concordance between these criteria.

METHODS

In the present study all information collected in Tabari cohort study(TCS) were utilized. These information were collected using a structural questionnaire and taking blood samples from all the participants. Blood pressure and anthropometric indices were measured for all participants by trained practitioners. Categorical variables were compared using chi-square test. In addition, the quantitative variables were compared between the two the groups using independent t-test. Kappa coefficient was estimated to show the agreement between the results of the three criteria.

RESULTS

The prevalences of Metabolic syndrome were 41.10%(CI 95%:40.10-42.02), 44.60%(CI 95%:43.61-45.54), and 30.80% (CI 95%:29.89-31.69) based on ATPIII, international IDF and IDF Iranian criteria respectively. The Kappa agreement coefficients between Iranian IDF with ATPIII definition and international IDF were estimated as 61.80% and 71.20% in the total population respectively.

CONCLUSION

Kappa coefficient showed that the Iranian IDF had a good agreement with International IDF and an intermediate agreement with the ATP-III. Considering more emphasis of international and Iranian IDF on waist circumference (WC), a better agreement between these two criteria is plausible. Regarding the high prevalence of abdominal obesity among Iranian population, applying these criteria to identify high risk persons might be helpful.

摘要

背景

代谢综合征由多种代谢紊乱共同存在所定义,如中心性肥胖、高甘油三酯、低高密度脂蛋白、高血糖和高血压,这会增加心血管疾病和糖尿病的风险。本研究的目的是在大规模人群队列研究中使用成人治疗小组第三次报告(ATP-III)、国际糖尿病联盟(IDF)和伊朗标准来估计代谢综合征的患病率,并确定这些标准之间的一致性。

方法

在本研究中,使用了塔巴里队列研究(TCS)中收集的所有信息。这些信息通过结构化问卷收集,并采集所有参与者的血样。由经过培训的人员为所有参与者测量血压和人体测量指标。分类变量使用卡方检验进行比较。此外,两组之间的定量变量使用独立t检验进行比较。估计卡帕系数以显示三个标准结果之间的一致性。

结果

根据ATPIII、国际IDF和IDF伊朗标准,代谢综合征的患病率分别为41.10%(95%CI:40.10-42.02)、44.60%(95%CI:43.61-45.54)和30.80%(95%CI:29.89-31.69)。在总体人群中,伊朗IDF与ATPIII定义和国际IDF之间的卡帕一致性系数分别估计为61.80%和71.20%。

结论

卡帕系数表明,伊朗IDF与国际IDF有良好的一致性,与ATP-III有中等程度的一致性。考虑到国际和伊朗IDF对腰围(WC)的更多强调,这两个标准之间可能有更好的一致性。鉴于伊朗人群中腹部肥胖的高患病率,应用这些标准来识别高危人群可能会有所帮助。

相似文献

引用本文的文献

本文引用的文献

3
Prevalence of metabolic syndrome in Iran: A meta-analysis.伊朗代谢综合征的患病率:一项荟萃分析。
Electron Physician. 2017 Oct 25;9(10):5402-5418. doi: 10.19082/5402. eCollection 2017 Oct.
9
Metabolic syndrome update.代谢综合征最新进展
Trends Cardiovasc Med. 2016 May;26(4):364-73. doi: 10.1016/j.tcm.2015.10.004. Epub 2015 Oct 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验